Procept Cash Flows Other Operating from 2010 to 2025
| PRCT Stock | USD 60.05 1.71 2.77% |
Cash Flows Other Operating | First Reported 2010-12-31 | Previous Quarter -2.1 M | Current Value -2.3 M | Quarterly Volatility 66 K |
Check Procept Biorobotics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Procept Biorobotics' main balance sheet or income statement drivers, such as Net Interest Income of 7 M, Interest Income of 11.4 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 17.76, Dividend Yield of 0.0 or PTB Ratio of 10.96. Procept financial statements analysis is a perfect complement when working with Procept Biorobotics Valuation or Volatility modules.
Procept | Cash Flows Other Operating |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Procept Stock Analysis
When running Procept Biorobotics' price analysis, check to measure Procept Biorobotics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procept Biorobotics is operating at the current time. Most of Procept Biorobotics' value examination focuses on studying past and present price action to predict the probability of Procept Biorobotics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procept Biorobotics' price. Additionally, you may evaluate how the addition of Procept Biorobotics to your portfolios can decrease your overall portfolio volatility.